Genetics of malignancy 2 Flashcards
Overcoming G1/S checkpoint
Upregulation of TFs (Myc oncogene) leads to increased cyclin D-cdk4 (G1-Cdk) activity
Rb protein
Active Rb binds and inactivates E2F
Active G1-Cdk phosphorylates Rb (inactive) and releases E2F
Active E2F allows S-phase genes to be transcribed and DNA synthesis
Rb lost in cancer, allowing unregulated S-phase entry
Variety of inactivating mutations in RB1 gene
Sporadic retinoblastoma
Somatic mutation leads to one mutant Rb allele. Second somatic mutation in other allele occurs
Leads to unilateral form (1 eye)
Cured by tumour removal
Familial retinoblastoma
Cancer-predisposition syndrome
1 allele already mutated in fertilised egg. First somatic mutation leaves two mutant Rb alleles
Leads to bilateral form (both eyes)
p53
Encoded by TP53 gene Regulates genes involved in cell cycle arrest (p21) DNA repair (XPA) Angiogenesis inhibition (TSP-1) Apoptosis
p53 activation
In normal conditions, p53 is bound by Mdm2 (E3 ub ligase) and degraded by the proteasome
DNA damage activates ATM/ATR kinase. Chk1/2 kinase activate and phosphorylate p53
Mdm2 polyubiquitinates itself
p53 activated
p21
p53 binds regulatory region of p21 gene and p21 transcribed
p21 binds and inactivates G1/S-Cdk, leading to cell cycle arrest
Arf
Expression induced by excessive Myc production (oncogenic signalling)
Binds and inactivates Mdm2
Stable active p53 leads to cell cycle arrest or apoptosis
Loss of p53 leads to apoptosis evasion and unregulated cell growth
Telomeres
Excess DNA that protects ends of chromosomes
Shorten with successive cell generations (regulation)
Telomerase
Resynthesises telomeres
Normally only expressed in germ and stem cells
TERT gene overexpressed in cancer leading to replicative immortality
Deregulation of cellular energetics
Normal cells divert most pyruvate to citric acid cycle
Cancer cells overexpress GLUT1 transporters and take up more glucose
Rely on aerobic glycolysis for energy, allowing more biosynthesis
Original hallmarks of cancer
Sustaining proliferative signalling (growth-promoting oncogenes)
Evading growth suppressors (loss of TSGs)
Activating invasion/metastasis
Enabling replicative immortality (telomerase)
Inducing angiogenesis
Resisting cell death (loss of TSGs and gain of oncogenes)
Thrombospondin-1
Extracellular matrix glycoprotein
Negative regulator of angiogenesis
Activates TGF-beta which negatively regulates haematopoiesis
Inactivation of p53 results in loss of TSP-1